Atlas Trials

Use of Clinical-trials and Simulation Models to Estimate Cost-effectiveness of Non-steroidal Mineralocorticoid Antagonists, RASi and SGLT2i as Triple Therapy With Type 2 Diabetes and Chronic Kidney Disease

Clinical trial NCT06727409 · RECRUITING

Trial details

NCT number
NCT06727409
Sponsor
Chinese University of Hong Kong
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Patients With Type 2 Diabetes
Start date
2024-12-12
Primary completion
2026-07-31
Enrollment
82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.